Wird geladen...
Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function
PURPOSE: Revefenacin, a long-acting muscarinic antagonist for nebulization, has been shown to improve lung function in patients with chronic obstructive pulmonary disease. Here we report pharmacokinetic (PK) and safety results from two multicenter, open-label, single-dose trials evaluating revefenac...
Gespeichert in:
| Veröffentlicht in: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6790214/ https://ncbi.nlm.nih.gov/pubmed/31632000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S203709 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|